Rawcliffe Adrian

Rawcliffe Adrian is listed in filings as Director at Wave Life Sciences Ltd.. This profile follows SEC Form 4 activity through Dec 10, 2025, including sale activity. Recent filings connect the profile to Wave Life Sciences Ltd. (WVE) and Adaptimmune Therapeutics plc (ADAPY). The current snapshot covers public activity from Aug 14, 2024 to Dec 10, 2025. Reported amounts are shown as $173.1K to $109.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.